Last reviewed · How we verify
Cohort 1: JMKX003142 and itraconazole — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Cohort 1: JMKX003142 and itraconazole (Cohort 1: JMKX003142 and itraconazole) — Jemincare.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Cohort 1: JMKX003142 and itraconazole TARGET | Cohort 1: JMKX003142 and itraconazole | Jemincare | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Cohort 1: JMKX003142 and itraconazole CI watch — RSS
- Cohort 1: JMKX003142 and itraconazole CI watch — Atom
- Cohort 1: JMKX003142 and itraconazole CI watch — JSON
- Cohort 1: JMKX003142 and itraconazole alone — RSS
Cite this brief
Drug Landscape (2026). Cohort 1: JMKX003142 and itraconazole — Competitive Intelligence Brief. https://druglandscape.com/ci/cohort-1-jmkx003142-and-itraconazole. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab